{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:16:19Z","timestamp":1778696179870,"version":"3.51.4"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016939","name":"Myriad Genetics Inc., Salt Lake City, UT, USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016939","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/01443615.2026.2665633","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:55:37Z","timestamp":1778694937000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Results of breast cancer risk assessment and hereditary cancer genetic testing in community obstetrics and gynaecology practice following a prospective quality Improvement initiative"],"prefix":"10.1080","volume":"46","author":[{"given":"Richard","family":"Waldman","sequence":"first","affiliation":[{"name":"Associates for Women\u2019s Medicine","place":["North Syracuse, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"DeFrancesco","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Connecticut","place":["Waterbury, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Feltz","sequence":"additional","affiliation":[{"name":"Lifeline Medical Associates, The Women\u2019s Care Source","place":["Morristown, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Welling","sequence":"additional","affiliation":[{"name":"Women\u2019s Health Connecticut","place":["Manchester, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wade","family":"Neiman","sequence":"additional","affiliation":[{"name":"Associates for Women\u2019s Health Services of Central VA, Inc","place":["Lynchburg, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Smith","sequence":"additional","affiliation":[{"name":"Myriad Genetics Inc","place":["Salt Lake City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan","family":"Schneider","sequence":"additional","affiliation":[{"name":"Myriad Genetics Inc","place":["Salt Lake City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Lenz","sequence":"additional","affiliation":[{"name":"Myriad Genetics Inc","place":["Salt Lake City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Johansen Taber","sequence":"additional","affiliation":[{"name":"Myriad Genetics Inc","place":["Salt Lake City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Royce","family":"Adkins","sequence":"additional","affiliation":[{"name":"Myriad Genetics Inc","place":["Salt Lake City, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"10","key":"e_1_3_4_2_1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/1940-6207.CAPR-21-0073","article-title":"Uptake of genetic testing among patients with cancer at risk for lynch syndrome in the National Health Interview Survey","volume":"14","author":"Actkins K. V.","year":"2021","unstructured":"Actkins, K. V., et al., 2021. Uptake of genetic testing among patients with cancer at risk for lynch syndrome in the National Health Interview Survey. Cancer Prevention Research (Philadelphia, Pa.), 14 (10), 927\u2013932.","journal-title":"Cancer Prevention Research (Philadelphia, Pa.)"},{"issue":"9","key":"e_1_3_4_3_1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.6004\/jnccn.2023.0046","article-title":"NCCN Guidelines\u00ae Insights: breast cancer screening and diagnosis, Version 1.2023","volume":"21","author":"Bevers T. B.","year":"2023","unstructured":"Bevers, T. B., et al., 2023. NCCN Guidelines\u00ae Insights: breast cancer screening and diagnosis, Version 1.2023. Journal of the National Comprehensive Cancer Network: JNCCN, 21 (9), 900\u2013909.","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"key":"e_1_3_4_4_1","volume-title":"StatPearls. Treasure Island (FL):","author":"Casaubon J.T.","year":"2026","unstructured":"Casaubon, J.T., Kashyap, S. and Regan, J-P., 2026. BRCA1 and BRCA2 mutations. In StatPearls. Treasure Island (FL): StatPearls Publishing."},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1200\/EDBK_238937","article-title":"Genetic counseling and testing in a community setting: quality, access, and efficiency","volume":"39","author":"Cohen S. A.","year":"2019","unstructured":"Cohen, S. A., et al., 2019. Genetic counseling and testing in a community setting: quality, access, and efficiency. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 39, e34\u2013e44. null","journal-title":"American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting"},{"issue":"10","key":"e_1_3_4_6_1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","article-title":"NCCN Guidelines\u00ae Insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, Version 2.2024","volume":"21","author":"Daly M. B.","year":"2023","unstructured":"Daly, M. B., et al., 2023. NCCN Guidelines\u00ae Insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network: JNCCN, 21 (10), 1000\u20131010.","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"5","key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/AOG.0000000000002916","article-title":"Hereditary cancer risk assessment and genetic testing in the community-practice setting","volume":"132","author":"DeFrancesco M. S.","year":"2018","unstructured":"DeFrancesco, M. S., et al., 2018. Hereditary cancer risk assessment and genetic testing in the community-practice setting. Obstetrics and Gynecology, 132 (5), 1121\u20131129.","journal-title":"Obstetrics and Gynecology"},{"issue":"66","key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"110635","DOI":"10.18632\/oncotarget.22372","article-title":"Single nucleotide polymorphisms and cancer susceptibility","volume":"8","author":"Deng N.","year":"2017","unstructured":"Deng, N., et al., 2017. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget, 8 (66), 110635\u2013110649.","journal-title":"Oncotarget,"},{"issue":"2","key":"e_1_3_4_9_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12282-014-0569-4","article-title":"Implementation of a risk assessment program in a breast-imaging community practice","volume":"23","author":"Destounis S.","year":"2016","unstructured":"Destounis, S., Arieno, A. and Morgan, R., 2016. Implementation of a risk assessment program in a breast-imaging community practice. Breast Cancer (Tokyo, Japan), 23 (2), 273\u2013278. null","journal-title":"Breast Cancer (Tokyo, Japan)"},{"issue":"23","key":"e_1_3_4_10_1","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1056\/NEJMsr1501341","article-title":"Gene-panel sequencing and the prediction of breast-cancer risk","volume":"372","author":"Easton D. F.","year":"2015","unstructured":"Easton, D. F., et al., 2015. Gene-panel sequencing and the prediction of breast-cancer risk. The New England Journal of Medicine, 372 (23), 2243\u20132257.","journal-title":"The New England Journal of Medicine"},{"issue":"8","key":"e_1_3_4_11_1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"147","author":"Ev E.","year":"2007","unstructured":"Ev, E., et al., 2007. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of Internal Medicine, 147 (8), 573\u2013577. null.","journal-title":"Annals of Internal Medicine,"},{"issue":"8","key":"e_1_3_4_12_1","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","volume":"24","author":"Heemskerk-Gerritsen B. A. M.","year":"2013","unstructured":"Heemskerk-Gerritsen, B. A. M., et al., 2013. Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis. Annals of Oncology: official Journal of the European Society for Medical Oncology, 24 (8), 2029\u20132035.","journal-title":"Annals of Oncology: official Journal of the European Society for Medical Oncology"},{"key":"e_1_3_4_13_1","doi-asserted-by":"crossref","unstructured":"Hereditary Cancer Syndromes and Risk Assessment ACOG COMMITTEE OPINION SUMMARY Number 793. Obstetrics & Gynecology 134(6):p 1366\u20131367 December 2019. | DOI: 10.1097\/AOG.0000000000003563","DOI":"10.1097\/AOG.0000000000003563"},{"issue":"10","key":"e_1_3_4_14_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.6004\/jnccn.2024.0061","article-title":"Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric, version 3.2024, NCCN Clinical Practice Guidelines In Oncology","volume":"22","author":"Hodan R.","year":"2024","unstructured":"Hodan, R., et al., 2024. Genetic\/familial high-risk assessment: colorectal, endometrial, and gastric, version 3.2024, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network: JNCCN, 22 (10), 695\u2013711.","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"key":"e_1_3_4_15_1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1200\/PO.20.00246","article-title":"Integrating clinical and polygenic factors to predict breast cancer risk in women undergoing genetic testing","volume":"5","author":"Hughes E.","year":"2021","unstructured":"Hughes, E., et al., 2021. Integrating clinical and polygenic factors to predict breast cancer risk in women undergoing genetic testing. JCO Precision Oncology, 5, 307\u2013316.","journal-title":"JCO Precision Oncology"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","first-page":"e2200084","DOI":"10.1200\/PO.22.00084","article-title":"Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition","volume":"6","author":"Hughes E.","year":"2022","unstructured":"Hughes, E., et al., 2022. Development and validation of a breast cancer polygenic risk score on the basis of genetic ancestry composition. JCO Precision Oncology, 6, e2200084.","journal-title":"JCO Precision Oncology"},{"issue":"1","key":"e_1_3_4_17_1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-015-1224-y","article-title":"Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk","volume":"15","author":"Judkins T.","year":"2015","unstructured":"Judkins, T., et al., 2015. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk. BMC Cancer, 15 (1), 215.","journal-title":"BMC Cancer,"},{"issue":"3","key":"e_1_3_4_18_1","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2013.2541","article-title":"Hereditary breast and ovarian cancer susceptibility genes","volume":"30","author":"Kobayashi H.","year":"2013","unstructured":"Kobayashi, H., et al., 2013. Hereditary breast and ovarian cancer susceptibility genes. Oncology Reports, 30 (3), 1019\u20131029.","journal-title":"Oncology Reports"},{"issue":"23","key":"e_1_3_4_19_1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker K. B.","year":"2017","unstructured":"Kuchenbaecker, K. B., et al., 2017. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Jama, 317 (23), 2402\u20132416.","journal-title":"Jama,"},{"issue":"1","key":"e_1_3_4_20_1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.2023.9526","article-title":"Germline genetic testing after cancer diagnosis","volume":"330","author":"Kurian A. W.","year":"2023","unstructured":"Kurian, A. W., et al., 2023. Germline genetic testing after cancer diagnosis. Jama, 330 (1), 43\u201351. null","journal-title":"Jama,"},{"issue":"11","key":"e_1_3_4_21_1","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/gim.2014.40","article-title":"Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients","volume":"16","author":"LaDuca H.","year":"2014","unstructured":"LaDuca, H., et al., 2014. Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genetics in Medicine: official Journal of the American College of Medical Genetics, 16 (11), 830\u2013837.","journal-title":"Genetics in Medicine: official Journal of the American College of Medical Genetics"},{"issue":"4","key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.6004\/jnccn.2022.7257","article-title":"Nationwide trends and determinants of germline BRCA1\/2 testing in patients with breast and ovarian cancer","volume":"21","author":"Lau-Min K. S.","year":"2023","unstructured":"Lau-Min, K. S., et al., 2023. Nationwide trends and determinants of germline BRCA1\/2 testing in patients with breast and ovarian cancer. Journal of the National Comprehensive Cancer Network: JNCCN, 21 (4), 351\u2013358.e4. null","journal-title":"Journal of the National Comprehensive Cancer Network: JNCCN"},{"issue":"6","key":"e_1_3_4_23_1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ajhg.2024.04.005","article-title":"Managing differential performance of polygenic risk scores across groups: real-world experience of the eMERGE Network","volume":"111","author":"Lewis A. C. F.","year":"2024","unstructured":"Lewis, A. C. F., et al., 2024. Managing differential performance of polygenic risk scores across groups: real-world experience of the eMERGE Network. American Journal of Human Genetics, 111 (6), 999\u20131005.","journal-title":"American Journal of Human Genetics"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.1016\/j.acra.2020.12.005","article-title":"A breast radiology department-operated, proactive same-day program identifies pathogenic breast cancer mutations in unaffected women","volume":"29","author":"Loving V. A.","year":"2022","unstructured":"Loving, V. A., et al., 2022. A breast radiology department-operated, proactive same-day program identifies pathogenic breast cancer mutations in unaffected women. Academic Radiology, 29 Suppl 1, S239\u2013S245. null","journal-title":"Academic Radiology"},{"issue":"7","key":"e_1_3_4_25_1","doi-asserted-by":"crossref","first-page":"101128","DOI":"10.1016\/j.gim.2024.101128","article-title":"Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors","volume":"26","author":"Mabey B.","year":"2024","unstructured":"Mabey, B., et al., 2024. Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors. Genetics in Medicine: official Journal of the American College of Medical Genetics, 26 (7), 101128.","journal-title":"Genetics in Medicine: official Journal of the American College of Medical Genetics"},{"issue":"10","key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","article-title":"Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons","volume":"26","author":"Manahan E. R.","year":"2019","unstructured":"Manahan, E. R., et al., 2019. Consensus guidelines on genetic testing for hereditary breast cancer from the American Society of Breast Surgeons. Annals of Surgical Oncology, 26 (10), 3025\u20133031.","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"e_1_3_4_27_1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","article-title":"Polygenic risk scores for prediction of breast cancer and breast cancer subtypes","volume":"104","author":"Mavaddat N.","year":"2019","unstructured":"Mavaddat, N., et al., 2019. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. American Journal of Human Genetics, 104 (1), 21\u201334.","journal-title":"American Journal of Human Genetics"},{"issue":"7","key":"e_1_3_4_28_1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jama.2019.8430","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women","volume":"322","author":"Nelson H. D.","year":"2019","unstructured":"Nelson, H. D., et al., 2019. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women. Jama, 322 (7), 666.","journal-title":"Jama,"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","unstructured":"Practice Bulletin No. 147 Lynch Syndrome. Obstetrics & Gynecology 124(5):p 1042-1054 November 2014. https:\/\/dx.doi.org\/10.1097\/01.AOG.0000456325.50739.72","DOI":"10.1097\/01.AOG.0000456325.50739.72"},{"issue":"21","key":"e_1_3_4_30_1","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck T. R.","year":"2002","unstructured":"Rebbeck, T. R., et al., 2002. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. The New England Journal of Medicine, 346 (21), 1616\u20131622.","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","article-title":"Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors","volume":"21","author":"Riley B. D.","year":"2012","unstructured":"Riley, B. D., et al., 2012. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. Journal of Genetic Counseling, 21 (2), 151\u2013161.","journal-title":"Journal of Genetic Counseling"},{"key":"e_1_3_4_32_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cancergen.2017.09.003","article-title":"Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories","volume":"218","author":"Rosenthal E. T.","year":"2017","unstructured":"Rosenthal, E. T., et al., 2017. Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer histories. Cancer Genetics, 218-219, 58\u201368.","journal-title":"Cancer Genetics"},{"issue":"6","key":"e_1_3_4_33_1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.mayocp.2019.02.017","article-title":"Hereditary cancer syndromes\u2014a primer on diagnosis and management","volume":"94","author":"Samadder N. J.","year":"2019","unstructured":"Samadder, N. J., et al., 2019. Hereditary cancer syndromes\u2014a primer on diagnosis and management. Mayo Clinic Proceedings, 94 (6), 1084\u20131098.","journal-title":"Mayo Clinic Proceedings,"},{"issue":"2","key":"e_1_3_4_34_1","first-page":"75","article-title":"American Cancer Society Guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow D.","year":"2007","unstructured":"Saslow, D., et al., 2007. American Cancer Society Guidelines for breast screening with MRI as an adjunct to mammography. CA: a Cancer Journal for Clinicians, 57 (2), 75\u201389.","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"6","key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"a036541","DOI":"10.1101\/cshperspect.a036541","article-title":"Cancer genetic counseling\u2014current practice and future challenges","volume":"10","author":"Schienda J.","year":"2020","unstructured":"Schienda, J. and Stopfer, J., 2020. Cancer genetic counseling\u2014current practice and future challenges. Cold Spring Harbor Perspectives in Medicine, 10 (6), a036541.","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"6","key":"e_1_3_4_36_1","first-page":"309","article-title":"Identifying and testing for hereditary susceptibility to common cancers","volume":"54","author":"Sifri R.","year":"2004","unstructured":"Sifri, R., Gangadharappa, S. and Acheson, L.S., 2004. Identifying and testing for hereditary susceptibility to common cancers. CA: a Cancer Journal for Clinicians, 54 (6), 309\u2013326.","journal-title":"CA: a Cancer Journal for Clinicians"},{"key":"e_1_3_4_37_1","unstructured":"Society AC n.d. Breast Cancer Facts and Figures 2024-2025. Atlanta: American Cancer Society. Available at: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/breast-cancer-facts-and-figures\/2024\/breast-cancer-facts-and-figures-2024.pdf."},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO-24-00716"},{"issue":"9","key":"e_1_3_4_39_1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer-susceptibility mutations","volume":"13","author":"Tung N.","year":"2016","unstructured":"Tung, N., et al., 2016. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nature Reviews. Clinical Oncology, 13 (9), 581\u2013588.","journal-title":"Nature Reviews. Clinical Oncology"},{"issue":"2","key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/AOG.0000000000005799","article-title":"Online screening and virtual patient education for hereditary cancer risk assessment and testing","volume":"145","author":"Waldman R. N.","year":"2025","unstructured":"Waldman, R. N., et al., 2025. Online screening and virtual patient education for hereditary cancer risk assessment and testing. Obstetrics and Gynecology, 145 (2), 177\u2013185.","journal-title":"Obstetrics and Gynecology"}],"container-title":["Journal of Obstetrics and Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/01443615.2026.2665633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:55:49Z","timestamp":1778694949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/01443615.2026.2665633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/01443615.2026.2665633"],"URL":"https:\/\/doi.org\/10.1080\/01443615.2026.2665633","relation":{},"ISSN":["0144-3615","1364-6893"],"issn-type":[{"value":"0144-3615","type":"print"},{"value":"1364-6893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijog20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijog20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-01-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2665633"}}